Wuhan Hvsen Biotechnology Co.,Ltd. (SHE:300871)

Wuhan Hvsen Biotechnology Revenue

Wuhan Hvsen Biotechnology had revenue of 419.78M CNY in the quarter ending September 30, 2026, a decrease of -4.01%. This brings the company's total for the last twelve months to 1.71B, up 2.35% year-over-year. In the year 2025, Wuhan Hvsen Biotechnology had annual revenue of 1.68B with 40.07% growth. That makes Wuhan Hvsen Biotechnology the 15,675th largest company in the world by revenue and 2,833rd in China.

• Revenue (ttm): 1.71B
• Revenue Growth: +2.35%
• P/S Ratio: 2.08
• Revenue / Employee: 1.51M
• Employees: 1,133
• Market Cap: 3.55B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• East China 408.59M 24.3%
• Central China 345.41M 20.5%
• North China 307.65M 18.3%
• South China 251.57M 15.0%
• Export 159.91M 9.5%
• Southwest China 88.46M 5.3%
• Northeast China 61.10M 3.6%
• Northwest China 58.56M 3.5%

Fiscal year ended Dec 31, 2025 See the full Wuhan Hvsen Biotechnology breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.68B	480.92M	40.07%
Dec 31, 2024	1.20B	180.57M	17.71%
Dec 31, 2023	1.02B	-3.14M	-0.31%
Jan 1, 2023	1.02B	26.68M	2.68%
Jan 1, 2022	996.22M	218.76M	28.14%

Data Source: S&P Global Market Intelligence Last updated: Oct 22, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 3, 2026

Data Sources Report a data error